Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
209542-49-4
31127-85-2
439114-13-3
518044-49-0
125220-94-2
119189-70-7
1820608-05-6 | 4-Methanesulfonyl-3-methylbenzonitrile | AA00I0F0 | MFCD27981301
1820665-50-6 | 2-Methyl-6-(2-methylpropoxy)pyridine | AA00I0NC | MFCD28385208
1820704-52-6 | 5-Bromo-1,7-dimethylindazol-3-amine | AA00I0U3 | MFCD28397284
1820741-32-9 | 1-(2-(tert-Butyldimethylsilyloxy)propyl)-1H-imidazole-2-carbaldehyde | AA00I11X | MFCD28369604
182628-12-2 | Cis-tert-butyl 3-phenylaziridine-2-carboxylate | AA00I1BN | MFCD24368281
1855897-91-4 | (E)-5-(2-Ethoxycarbonylethen-1-yl)-2-fluorophenylboronic acid | AA00I1HQ | MFCD18087692
1879010-27-1 | 1,2-Bis(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyne | AA00I1TB | MFCD22124729
191043-81-9 | Methanesulfonamide, n-(4-bromophenyl)-n-(methylsulfonyl)- | AA00I2R3 | MFCD27946748
194668-38-7 | tert-Butyl 4-(5-cyanopyridin-2-yloxy)piperidine-1-carboxylate | AA00I2ZR | MFCD08692372
1955557-41-1 | 1-Pyrrolidin-3-yl-1h-1,2,3-triazole dihydrochloride | AA00I3BH | MFCD28505134